We only have this paper's title and publication details.
Read it at the sourcePhase II trial assesses cadonilimab + neoadjuvant chemotherapy in head and neck cancer, suggesting potential benefits.
Representativeness of Study Participants
No takes yet. Share an insight, caveat, or question.
Cao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: